The Molecular Pharmacology Training Program fulfills a critical need in pre-doctoral training at NYU School of Medicine, as it is the sole program devoted to the Pharmacological Sciences, therapeutics and drug design. The Molecular Pharmacology Training Program is broad-based but unified by the single major objective of this program: to produce trainees who are skilled, rigorous and imaginative scientists in the area of pharmacological sciences with an in depth focus on therapeutics. The overall long-term objective of the training program is to train subsequent generations of researchers in the study of pharmacological sciences and to apply these principles to understanding and treating malignancies and neurodegenerative disease. The training program is comprised of 38 faculty who are highly productive scientists with extensive mentoring experience. The faculty trainers all share a common interest in understanding basic pharmacological mechanisms as their contribution to chronic and life-threatening human disease. Broad training in the molecular pharmacology, strategies for drug intervention and drug delivery, mechanisms of drug resistance, processes that determine cellular responses to therapeutic agents and translational research is provided to all trainees in a highly interactive scientific environment. The mission of this training program will be achieved in a rigorous and intellectually demanding research environment spanning basic science and clinical departments that encourages diversity. Trainees will acquire the ability to critically evaluate the literature and scientific data and wil develop written and presentation skills. Training of students includes an individual development plan, and rigorous course work in principles of pharmacology, receptor pharmacology, drug design, protein modifications, quantitative skills, and translational research. The training program has established a successful system for evaluating, mentoring, and soliciting trainee feedback. Furthermore, all trainees participate in a weekly program-wide work-in-progress seminar series, an annual retreat, lectures focusing on ethical conduct in science, and career development. Our tradition of strong programmatic leadership and guidance, a well- crafted training program with proven results spanning more than 16 years, experienced and committed faculty trainers, productive and diverse trainees, in an outstanding scientific environment with key expertise in signal transduction, pharmacology, bioinformatics, structural biology, neurobiology will enable our continued success going forward. The Molecular Pharmacology Training Program request funds to continue supporting 4 pre- doctoral trainees. These trainees represent the next generation of scientists who will contribute to the development of novel pharmacological therapies to treat diseases. Significantly, trainees educated in Pharmacological Sciences continue to be of great importance to protect our nation and society at large against ageing-related diseases like cancer, diabetes and neurodegeneration.

Public Health Relevance

Millions of pre-mature deaths and tremendous cost to society are associated with the inability to effectively treat cancer and neurodegenerative diseases with existing pharmacological agents. These and other sobering statistics all too clear illustrate the need to recruit and train the next generation of scientists with expertise in pharmacology to the study how malignancies and neurodegenerative disorders are caused in humans and to design/develop new therapies against these diseases. This application proposes to educate trainees in basic pharmacological sciences as these scientists continue to be of great importance to protect our nation and society at large against the continuing threat posed by these ageing-related diseases.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Program Officer
Okita, Richard T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Schools of Medicine
New York
United States
Zip Code
DiMauro, T; Cantor, D J; Bainor, A J et al. (2015) Transcriptional repression of Sin3B by Bmi-1 prevents cellular senescence and is relieved by oncogene activation. Oncogene 34:4011-7
Bhatla, Teena; Jones, Courtney L; Meyer, Julia A et al. (2014) The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions. J Pediatr Hematol Oncol 36:413-8
Lin, Xianming; O'Malley, Heather; Chen, Chunling et al. (2014) Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis and arrhythmias in murine hearts. J Physiol :
Dandekar, Smita; Romanos-Sirakis, Eleny; Pais, Faye et al. (2014) Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia. Br J Haematol 167:87-99
Kim, Eugene E; Shekhar, Akshay; Lu, Jia et al. (2014) PCP4 regulates Purkinje cell excitability and cardiac rhythmicity. J Clin Invest 124:5027-36
Song, Lintao; Zhu, Yanlin; Wang, Huiyan et al. (2014) A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog. Biomaterials 35:5206-15
Jones, Courtney L; Bhatla, Teena; Blum, Roy et al. (2014) Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model. J Biol Chem 289:20502-15
Wengrod, Jordan; Martin, Leenus; Wang, Ding et al. (2013) Inhibition of nonsense-mediated RNA decay activates autophagy. Mol Cell Biol 33:2128-35
Bingham, Taiese Crystal; Parathath, Saj; Tian, Heather et al. (2012) Cholesterol 27-hydroxylase but not apolipoprotein apoE contributes to A2A adenosine receptor stimulated reverse cholesterol transport. Inflammation 35:49-57
Beenken, Andrew; Eliseenkova, Anna V; Ibrahimi, Omar A et al. (2012) Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1. J Biol Chem 287:3067-78

Showing the most recent 10 out of 25 publications